As. Oro et al., REGULATION OF DISEASE SUSCEPTIBILITY - DECREASED PREVALENCE OF IGE-MEDIATED ALLERGIC DISEASE IN PATIENTS WITH MULTIPLE-SCLEROSIS, Journal of allergy and clinical immunology, 97(6), 1996, pp. 1402-1408
The development of restricted cytokine profiles by subsets of CD4(+) T
cells is a pivotal point in the regulation of immune responses. T cel
ls producing Th1 cytokines (IL-2 and interferon-gamma) induce cell-med
iated immunity, whereas T cells producing Th2 cytokines (IL-4, IL-5, a
nd IL-10) play a prominent role in the induction of humoral immunity.
We examined a group of patients with multiple sclerosis, a disease cau
sed by excess production of Th1 cytokines in myelin-reactive T cells,
and control patients with noninflammatory neuroconvulsive disorders, f
or the presence of allergic disease, which is caused by excess product
ion of Th2 cytokines in allergen-specific T cells. The patients with m
ultiple sclerosis had significantly fewer allergic symptoms, a lower n
umber of positive allergen-specific IgE test results, and lower compos
ite allergy indexes than control subjects. These results demonstrate t
hat the prevalence of IgE-mediated allergic disease is decreased in a
group of patients with multiple sclerosis and support the hypothesis t
hat genetic factors that promote susceptibility to Th1-medicated infla
mmatory disease in human beings protect against the development of Th2
-medicated disease.